Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
Biography and Research Information
OverviewAI-generated summary
Tsigereda Weldemichael's research focuses on the intersection of pharmacology and cellular damage, particularly in the context of kidney cells. Recent work has investigated how therapeutic agents, specifically EET-based therapeutics, can mitigate damage associated with sorafenib treatment, a known chemotherapy drug. This research has explored the impact of these therapeutics on glomerular cells and podocytes, which are critical components of the kidney's filtration system. Weldemichael's investigations also extend to the molecular mechanisms underlying cancer, with publications examining potent inhibitors of FLT3-ITD mutations, including those resistant to existing treatments like gilteritinib. This work contributes to the understanding of acute myeloid leukemia and the development of targeted therapies. Collaborations include work with Phuc Tran, Abdul H. Khan, Shobanbabu Bommagani, and Abhishek Mishra at the University of Arkansas for Medical Sciences, with shared publications indicating active research partnerships.
Metrics
- h-index: 4
- Publications: 5
- Citations: 75
Selected Publications
-
Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats (2026)
-
Renoprotective approaches against anthracycline nephrotoxicity (2026)
-
EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage (2025)
-
Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications (2025)
-
CD36-mediated endocytosis of proteolysis-targeting chimeras (2025)
-
An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L (2023)
-
Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome (2022)
Collaboration Network
Top Collaborators
Phuc Tran
University of Arkansas for Medical Sciences
3 shared publications
In database
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Hongyu Li
The University of Texas Health Science Center at San Antonio (US)
3 shared publications
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- CD36-mediated endocytosis of proteolysis-targeting chimeras
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
John D. Imig
Medical College of Wisconsin
3 shared publications
In database
- EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage
- Renoprotective approaches against anthracycline nephrotoxicity
- Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats
Samaneh Goorani
University of Arkansas for Medical Sciences
2 shared publications
In database
- EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage
- Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats
Md. Abdul Hye Khan
University of Arkansas for Medical Sciences
2 shared publications
In database
- Renoprotective approaches against anthracycline nephrotoxicity
- Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats
Zhichao Liu
United States Food and Drug Administration (US)
1 shared publication
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
Xiuqi Wang
University of Arkansas for Medical Sciences
1 shared publication
In database
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Rosa Anna DeFilippis
University of California, San Francisco (US)
1 shared publication
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Gunaganti Naresh
University of Arkansas for Medical Sciences
1 shared publication
In database
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Yuet‐Kin Leung
University of Arkansas for Medical Sciences
1 shared publication
In database
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Neil P. Shah
University of California, San Francisco (US)
1 shared publication
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Zheng‐Yu Wang
The University of Texas Health Science Center at San Antonio
1 shared publication
In database
- CD36-mediated endocytosis of proteolysis-targeting chimeras
Bo‐Syong Pan
Wake Forest University (US)
1 shared publication
- CD36-mediated endocytosis of proteolysis-targeting chimeras
Rajesh Manne
Wake Forest University (US)
1 shared publication
- CD36-mediated endocytosis of proteolysis-targeting chimeras
Jungang Chen
Winthrop Rockefeller Foundation (US)
1 shared publication
- CD36-mediated endocytosis of proteolysis-targeting chimeras
Similar Researchers
Based on overlapping research topics
Mathew Newman
Arkansas State University
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Han M
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Fabricio Medina‐ Bolivar
Arkansas State University
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
April Clawson
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Abul B. Kazi
University of Arkansas at Pine Bluff
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Fabio Ntagwabira
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications